Cargando…
Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer
Colorectal cancer is one of the most common tumors worldwide and at least 50 % of patients with this disease develop metastases. In this setting, additional treatment options are needed for patients presenting disease progression after exhausting all standard therapies. Regorafenib is an orally admi...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194027/ https://www.ncbi.nlm.nih.gov/pubmed/25223744 http://dx.doi.org/10.1007/s12094-014-1212-8 |